Literature DB >> 12586674

Leishmaniasis: new approaches to disease control.

Clive R Davies1, Paul Kaye, Simon L Croft, Shyam Sundar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12586674      PMCID： PMC1125241          DOI： 10.1136/bmj.326.7385.377

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  26 in total

1.  Diagnosing visceral leishmaniasis with the recombinant K39 strip test: experience from the Sudan.

Authors:  E E Zijlstra; Y Nur; P Desjeux; E A Khalil; A M El-Hassan; J Groen
Journal:  Trop Med Int Health       Date:  2001-02       Impact factor: 2.622

2.  Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic.

Authors:  S Sundar; D K More; M K Singh; V P Singh; S Sharma; A Makharia; P C Kumar; H W Murray
Journal:  Clin Infect Dis       Date:  2000-10       Impact factor: 9.079

3.  Latex agglutination test for the detection of urinary antigens in visceral leishmaniasis.

Authors:  Z J Attar; M L Chance; S el-Safi; J Carney; A Azazy; M El-Hadi; C Dourado; M Hommel
Journal:  Acta Trop       Date:  2001-01-15       Impact factor: 3.112

4.  Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis.

Authors:  T K Jha; S Sundar; C P Thakur; P Bachmann; J Karbwang; C Fischer; A Voss; J Berman
Journal:  N Engl J Med       Date:  1999-12-09       Impact factor: 91.245

Review 5.  Leishmaniasis: current status of vaccine development.

Authors:  E Handman
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

6.  Spraying houses in the Peruvian Andes with lambda-cyhalothrin protects residents against cutaneous leishmaniasis.

Authors:  C R Davies; E A Llanos-Cuentas; P Campos; J Monge; E Leon; J Canales
Journal:  Trans R Soc Trop Med Hyg       Date:  2000 Nov-Dec       Impact factor: 2.184

7.  Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trial.

Authors:  S Sundar; G Agrawal; M Rai; M K Makharia; H W Murray
Journal:  BMJ       Date:  2001-08-25

8.  Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan.

Authors:  E A Khalil; A M El Hassan; E E Zijlstra; M M Mukhtar; H W Ghalib; B Musa; M E Ibrahim; A A Kamil; M Elsheikh; A Babiker; F Modabber
Journal:  Lancet       Date:  2000-11-04       Impact factor: 79.321

9.  A randomized controlled trial of insecticide-treated bednets and chaddars or top sheets, and residual spraying of interior rooms for the prevention of cutaneous leishmaniasis in Kabul, Afghanistan.

Authors:  H Reyburn; R Ashford; M Mohsen; S Hewitt; M Rowland
Journal:  Trans R Soc Trop Med Hyg       Date:  2000 Jul-Aug       Impact factor: 2.184

10.  Protective immunity using recombinant human IL-12 and alum as adjuvants in a primate model of cutaneous leishmaniasis.

Authors:  R T Kenney; D L Sacks; J P Sypek; L Vilela; A A Gam; K Evans-Davis
Journal:  J Immunol       Date:  1999-10-15       Impact factor: 5.422
View more
  58 in total

1.  The effect of removing potentially infectious dogs on the numbers of canine Leishmania infantum infections in an endemic area with high transmission rates.

Authors:  Gabriel Grimaldi; Antonio Teva; Claudiney B Santos; Adelson L Ferreira; Aloísio Falqueto
Journal:  Am J Trop Med Hyg       Date:  2012-06       Impact factor: 2.345

2.  Leishmaniasis also occurs in Mediterranean countries.

Authors:  Giovanna Russo
Journal:  BMJ       Date:  2003-05-10

Review 3.  Diagnosis of visceral leishmaniasis.

Authors:  Pankaj Srivastava; Anand Dayama; Sanjana Mehrotra; Shyam Sundar
Journal:  Trans R Soc Trop Med Hyg       Date:  2010-11-11       Impact factor: 2.184

4.  Probing elongating and branching β-D-galactosyltransferase activities in Leishmania parasites by making use of synthetic phosphoglycans.

Authors:  Olga V Sizova; Andrew J Ross; Irina A Ivanova; Vladimir S Borodkin; Michael A J Ferguson; Andrei V Nikolaev
Journal:  ACS Chem Biol       Date:  2011-04-11       Impact factor: 5.100

5.  Probing the structure of Leishmania donovani chagasi DHFR-TS: comparative protein modeling and protein-ligand interaction studies.

Authors:  Lakshmi Maganti; Prabu Manoharan; Nanda Ghoshal
Journal:  J Mol Model       Date:  2010-02-21       Impact factor: 1.810

6.  Serological screening confirms the re-emergence of canine leishmaniosis in urban and rural areas in Governador Valadares, Vale do Rio Doce, Minas Gerais, Brazil.

Authors:  Luiz Cosme Cotta Malaquias; Rodrigo do Carmo Romualdo; José Batista do Anjos; Rodolfo Cordeiro Giunchetti; Rodrigo Corrêa-Oliveira; Alexandre Barbosa Reis
Journal:  Parasitol Res       Date:  2006-08-29       Impact factor: 2.289

7.  Structural analysis of trypanosomal sirtuin: an insight for selective drug design.

Authors:  Simranjeet Kaur; Amol V Shivange; Nilanjan Roy
Journal:  Mol Divers       Date:  2009-04-29       Impact factor: 2.943

Review 8.  Drug resistance in leishmaniasis.

Authors:  Simon L Croft; Shyam Sundar; Alan H Fairlamb
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

Review 9.  Elimination of visceral leishmaniasis on the Indian subcontinent.

Authors:  Om Prakash Singh; Epco Hasker; Marleen Boelaert; Shyam Sundar
Journal:  Lancet Infect Dis       Date:  2016-09-28       Impact factor: 25.071

10.  The biology and control of leishmaniasis vectors.

Authors:  David M Claborn
Journal:  J Glob Infect Dis       Date:  2010-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.